Arden Moscati

Title: The Innovative Contributions of Arden Moscati

Introduction

Arden Moscati is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of immunology, particularly in the treatment of immune disorders. With a total of 3 patents, Moscati's work has the potential to impact many lives.

Latest Patents

Moscati's latest patents include groundbreaking methods for treating immune disorders. One patent focuses on "Materials and methods of treating MHC-I-opathy risk haplotypes." This disclosure provides methods for treating subjects with immune disorders by administering a therapeutically effective amount of an Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) inhibitor in combination with an HLA-A29 or HLA-B27 inhibitory nucleic acid molecule. Another patent addresses "Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors." This patent outlines methods for treating subjects with uveitis and identifying those at increased risk of developing the condition.

Career Highlights

Arden Moscati is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work at Regeneron has positioned him as a key player in the development of therapies aimed at treating complex immune-related conditions.

Collaborations

Moscati collaborates with talented individuals in his field, including Sahar Gelfman and Ann Ligocki. These partnerships enhance the research and development efforts at Regeneron, fostering an environment of innovation and discovery.

Conclusion

Arden Moscati's contributions to immunology through his patents and work at Regeneron Pharmaceuticals, Inc. highlight his commitment to advancing medical science. His innovative approaches to treating immune disorders are paving the way for future breakthroughs in the field.